VANCOUVER, BC, Dec. 20, 2024 /PRNewswire/ – The International Society for Cell & Gene Therapy (ISCT) celebrates the US Food and Drug Administration’s (FDA) landmark decision to approve Mesoblast Limited’s allogenic, bone marrow-derived mesenchymal stromal cell (MSC) product, RYONCIL®…